AG009HTY

126100-97-8 | Dimiracetam

Chemical structure of Dimiracetam, CAS 126100-97-8
AG009HTY
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 126100-97-8
Catalog Number AG009HTY(AGN-PC-0A9GPH)
Chemical Name Dimiracetam
IUPAC Name 3,6,7,7a-tetrahydro-1H-pyrrolo[1,2-a]imidazole-2,5-dione
InChI InChI=1S/C6H8N2O2/c9-5-3-8-4(7-5)1-2-6(8)10/h4H,1-3H2,(H,7,9)
InChI Key XTXXOHPHLNROBN-UHFFFAOYSA-N
MDL Number MFCD00867777
Molecular Formula C6H8N2O2
Molecular Weight 140.1399
SMILES O=C1CCC2NC(=O)CN12
Synonyms
dihydro-1H-pyrrolo(1,2-a)imidazole-2,5-(3H,6H)-dione, dimiracetam, Dimiracetam, 126100-97-8, Dimiracetam [INN], dihydro-1h-pyrrolo[1,2-a]imidazole-2,5(3h,6h)-dione, Dihydro-1H-pyrrolo(1,2-a)imidazole-2,5(3H,6H)-dione, Tetrahydro-5h-pyrrolo[1,2-a]imidazole-2,5(3h)-dione, 1H-Pyrrolo(1,2-a)imidazole-2,5(3H,6H)-dione, dihydro-, (+-)-Dihydro-1H-pyrrolo(1,2-a)imidazole-2,5(3H,6H)-dione, 1H-Pyrrolo[1,2-a]imidazole-2,5(3H,6H)-dione, dihydro-, AC1L24BK, AC1Q6M4F, SCHEMBL195256, CHEMBL337612, XTXXOHPHLNROBN-UHFFFAOYSA-N, MFCD00867777, AKOS006272567, DB13018, SB17242, LS-139362, CS-0026742, Tetrahydro-pyrrolo[1,2-a]imidazole-2,5-dione, 2,5-Dioxohexahydro-1H-pyrrolo[1,2-a]imidazole, 2.5-Dioxohexahydro-1H-pyrrolo[1,2-a]imidazole, 2,5-Dioxohexahydro-1-H-pyrrolo[1,2-a]imidazole, hexahydro-1H-pyrrolo[1,2-a]imidazolidine-2,5-dione, 3,6,7,7a-tetrahydro-1H-pyrrolo[1,2-a]imidazole-2,5-dione, Dimiracetam, Neurotune, UNII-4AW7F70MZO, D0T9DN, 4AW7F70MZO, C6-H8-N2-O2, CID65955, BND-11624, NT-11624, C085079, t-Butyl (2R,3R)-3-amino-2-hydroxy-3-phenylpropanoate, dihydro-1H-pyrrolo(1,2-a)imidazole-2,5-(3H,6H)-dione, NMDA receptor antagonist (oral, neuropathic pain/osteoarthritic pain), Neurotune,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited